The present study was designed to obtain a basic pharmacological profi
le of venom from the inland taipan (Oxyuranus microlepidotus). Venom (
0.05-50 mu g/ml) produced dose-dependent contractions in guinea-pig il
eum, which could not be reproduced upon second administration. The cyc
looxygenase inhibitor indomethacin (1 mu M), a preceding anaphylactic
response induced by egg albumin and inactivation of phospholipase A(2)
(PLA(2)) by incubation with 4-bromophenacyl bromide (1.8 mM) all sign
ificantly inhibited responses to venom (0.5 mu g/ml). Venom (0.5 mu g/
ml) caused inhibition of stimulation-induced contractions in the prost
atic segment of rat vas deferens which was not significantly affected
by the alpha(2)-adrenoceptor antagonist idazoxan (0.3 mu M). Venom (10
mu g/ml) caused time-dependent inhibition of the rat electrically sti
mulated phrenic nerve-diaphragm preparation, positive inotropic and ch
ronotropic responses in rat isolated atria and relaxation in rat endot
helium-denuded and -intact isolated aortae. In endothelium-intact aort
ae, the nitric oxide synthase inhibitor N-nitro-L-arginine (NOLA, 0.1
mM) significantly inhibited the response to venom (10 mu g/ml). Venom
(50 mu g/kg, i.v.) caused an immediate drop in blood pressure followed
by cardiovascular collapse in anaesthetised rats. Venom (10 mu g/kg,
i.v.) caused a gradual fall in blood pressure which was sometimes acco
mpanied by a temporary cessation of respiration. A PLA(2) assay detect
ed the presence of PLA(2) in the venom. These results suggest that the
venom contains a component capable of causing the synthesis of arachi
donic acid metabolites and a component capable of relaxing vascular sm
ooth muscle. The inhibitory effect on the phrenic nerve-diaphragm is p
robably due to the previously identified neurotoxin (paradoxin). (C) 1
998 Elsevier Science Ltd. All rights reserved.